BC Platforms

BC Platforms is an analytics company in Zurich, Switzerland, founded in 1997. It has raised $30.0M across 2 rounds, most recently a $20.0M Growth Equity in November 2022.

Unlocking the full potential of global health data

Headquarters
Zurich
Founded
1997
Business Model
B2B
Total Funding
$30.0M
Last Round
$20.0M Growth EquityNov 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

BC Platforms provides real-world data, predictive analytics, and secure technology for healthcare and life-sciences organizations. Its AI-enabled federated platform connects hospitals, research centers, and biobanks while supporting harmonization, analysis, and sharing of multimodal data. Customers use its datasets, research environments, and evidence networks to inform drug development, precision medicine, population-health decisions, and clinical and post-launch evidence generation.

Summary

It has raised $30.0M in total across 2 rounds, most recently a $20.0M Growth Equity round in Nov 2022. Investors include Jolt Capital, Debiopharm Innovation and Tesi.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityNov 2022
$20.0M

Sign up to see all 2 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series CTotal funding$363.0MJan 2025
Octant Bio

Small molecule correctors for protein misfolding, enabled by a synthetic biology, high throughput...

Los Angeles, United States51–200Healthcare, Biotech
Series CTotal funding$290.2MOct 2025
Vir

Clinical-stage biopharmaceutical company leveraging the immune system to develop medicines for in...

San Francisco, United States201–500Biotech, Healthcare
Growth EquityTotal funding$250.0MOct 2024
InventisBioIPO

InventisBio develops clinical-stage medicines for oncology, autoimmune diseases, and metabolic di...

Shanghai, China11–50Biotech, Life Sciences
Series DTotal funding$247.0MSep 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BC Platforms on Indexed.vc
<a href="https://indexed.vc/companies/bc-platforms"><img src="https://indexed.vc/api/badge/company/bc-platforms" alt="BC Platforms on Indexed.vc" width="260" height="76" /></a>